Answers are grounded in this paper and cite their sources.
Opioids are the strongest analgesics available in medicine and they are used when non-opioid analgesics are ineffective. However, they may cause side effects that may limit their use and therapeutic effect. Therefore, newer opioids with limited adverse effects while preserving analgesic efficacy may have a prominent role in the pharmacotherapy of severe pain. This narrative review focuses on three opioids (tapentadol, cebranopadol and oxycodone/naloxone) that display different pharmacodynamic and pharmacokinetic properties compared to widely used opioids with provision of effective analgesia and less adverse effects. It highlights a need of individual and tailored approach to address patient needs regarding management of pain and minimizing adverse effects which ultimately preserves possible highest patients and caregivers quality of life.
No takes yet. Share an insight, caveat, or question.
Zajączkowska et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: